Molecular Construction and Anti-Bladder Cancer Study of Novel TOP1/PARP1 Dual-Target Inhibitors. Wang W, Li D, Liu J, Li L, et al. J Med Chem 2026 Jul 27. doi: 10.1021/acs.jmedchem.6c01714.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang W, Li D, Liu J, Li L, et al. Molecular Construction and Anti-Bladder Cancer Study of Novel TOP1/PARP1 Dual-Target Inhibitors. J Med Chem 2026 Jul 27. doi: 10.1021/acs.jmedchem.6c01714.
PMID: 42504569